Wikipedia -WSS

Wikipedia

author：explore 2025-09-30 17:05:20 - browse：39

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Commercial surrogacy can be ethical, despite pope’s claims

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

Medicare drug price negotiation’s day in court

General Catalyst, Summa Health deal will turn on physician buy

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Even great ERs can’t make up for American health disparities

With competition flaring, obesity drug hits goal in liver disease study

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

The high cost of giving birth even with insurance

Community Health Systems hospitals under DOJ investigation

FDA approval of Sarepta Duchenne genetic therapy gives me hope

General Catalyst, Summa Health deal will turn on physician buy

United colonoscopy coverage change 'may cost lives,' doctors say

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Harvard botanist who searched for psychedelics in the Amazon

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Community Health Systems hospitals under DOJ investigation

entertainment

Alabama IVF ruling threatens families facing fatal genetic disease

Time to name cancers by genetics, not organ of origin, expert says

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Medicare drug price negotiation’s day in court

Do digital therapeutics have a future in medicine?

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

knowledge

focus

leisure time

knowledge